Bioequivalence of efavirenz /emtricitabine /tenofovir disoproxil fumarate single-tablet regimenMATHIAS, Anita A; HINKLE, John; MENNING, Mark et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 167-173, issn 1525-4135, 7 p.Article

Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-91 37RAMANATHAN, Srinivasan; GONG SHEN; CHENG, Andrew et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 3, pp 274-279, issn 1525-4135, 6 p.Article

Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical PracticeVALLECILLO, Gabriel; DOMINGO, Pere; MALLOLAS, Josep et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 165-170, issn 0889-2229, 6 p.Article

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients : 144-Week AnalysisARRIBAS, Jose R; POZNIAK, Anton L; TOOLE, John J et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 1, pp 74-78, issn 1525-4135, 5 p.Article

Microdetermination of Emtricitabine in Human Plasma by Liquid Chromatography/Tandem Mass SpectrometryYADAV, Manish; SINGHAL, Puran; GOSWAMI, Sailendra et al.Journal of AOAC International. 2009, Vol 92, Num 6, pp 1681-1689, issn 1060-3271, 9 p.Article

Emtricitabine (FTC) for the treatment of HIV infectionNELSON, M; SCHIAVONE, M.International journal of clinical practice (Esher). 2004, Vol 58, Num 5, pp 504-510, issn 1368-5031, 7 p.Article

Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients: Randomized, Open-Label Pilot StudyMILLS, Anthony; MILDVAN, Donna; HEERA, Jayvant et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 2, pp 164-170, issn 1525-4135, 7 p.Article

Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naïve Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934MARGOT, Nicolas A; ENEJOSA, Jeff; CHENG, Andrew K et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 209-221, issn 1525-4135, 13 p.Article

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients : Virologic, immunologic, and morphologic changes-A 96-week analysisPOZNIAK, Anton L; GALLANT, Joel E; CHENG, Andrew K et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 535-540, issn 1525-4135, 6 p.Article

Addition of Single-Dose Tenofovir and Emtricitabine to Intrapartum Nevirapine to Reduce Perinatal HIV TransmissionCHI, Benjamin H; CHINTU, Namwinga; CANTRELL, Ronald A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 2, pp 220-223, issn 1525-4135, 4 p.Article

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: A pilot randomised trialSOFIA, Alessandro; DANISE, Anna; GALLI, Laura et al.Journal of clinical virology. 2010, Vol 47, Num 3, pp 253-257, issn 1386-6532, 5 p.Article

Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityROSS, Lisa L; PARKIN, Neil; GERONDELIS, Peter et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 567-570, issn 1525-4135, 4 p.Article

Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patientsROUSSEAU, Franck S; WAKEFORD, Charles; MOMMELA-MARIN, Herve et al.The Journal of infectious diseases. 2003, Vol 188, Num 11, pp 1652-1658, issn 0022-1899, 7 p.Article

Reproductive toxicology profile of emtricitabine in mice and rabbitsSZCZECH, George M; WANG, Laurene H; WALSH, John P et al.Reproductive toxicology (Elmsford, NY). 2003, Vol 17, Num 1, pp 95-108, issn 0890-6238, 14 p.Article

Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing RegimensSVICHER, Valentina; ALTERI, Claudia; ZACCARELLI, Mauro et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 3, pp 336-344, issn 1525-4135, 9 p.Article

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 96 ResultsROCKSTROH, Jürgen K; DEJESUS, Edwin; FORDYCE, Marshall W et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 5, pp 483-486, issn 1525-4135, 4 p.Article

Drug-Susceptible HIV-1 Infection Despite Intermittent Fixed-Dose Combination Tenofovir/Emtricitabine as Prophylaxis Is Associated With Low-Level Viremia, Delayed Seroconversion, and an Attenuated Clinical CoursePRADA, Nicole; DAVIS, Brandi; JEAN-PIERRE, Patrick et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 2, pp 117-122, issn 1525-4135, 6 p.Article

The HIV-1 Reverse Transcriptase MI841 Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral FitnessKULKARNI, Rima; BABAOGLU, Kerim; LANSDON, Eric B et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 1, pp 47-54, issn 1525-4135, 8 p.Article

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabineMANSOUR, Wael; DUCANCELLE, Alexandra; LE GAL, Frederic et al.Journal of clinical virology. 2010, Vol 47, Num 1, pp 97-99, issn 1386-6532, 3 p.Article

Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1―Infected PatientsDEJESUS, Edwin; YOUNG, Benjamin; MCCOLL, Damian et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 2, pp 163-174, issn 1525-4135, 12 p.Article

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infectionWANG, Laurene H; BEGLEY, John; CLAIRE, Robert L. St. III et al.AIDS research and human retroviruses. 2004, Vol 20, Num 11, pp 1173-1182, issn 0889-2229, 10 p.Article

Impact of Low Abundance HIV Variants on Response to Ritonavir-Boosted Atazanavir or Fosamprenavir Given Once Daily with Tenofovir/Emtricitabine in Antiretroviral-Naive HIV-Infected PatientsROSS, Lisa L; WEINBERG, Winkler G; DEJESUS, Edwin et al.AIDS research and human retroviruses. 2010, Vol 26, Num 4, pp 407-417, issn 0889-2229, 11 p.Article

Effects of HAART on Platelet-Activating Factor Metabolism in Naive HIV-Infected Patients I: Study of the Tenofovir-DF/Emtricitabine/Efavirenz HAART RegimenCHINI, Maria; TSOUPRAS, Alexandros B; MANGAFAS, Nikos et al.AIDS research and human retroviruses. 2012, Vol 28, Num 8, pp 766-775, issn 0889-2229, 10 p.Article

Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3_M184V Mutant by Intermittent Prophylaxis with TruvadaCONG, Mian-Er; YOUNGPAIROJ, Ae S; GERARDO GARCIA-LERMA, J et al.Journal of virology. 2011, Vol 85, Num 15, pp 7933-7936, issn 0022-538X, 4 p.Article

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HN-1-infected adults with viral suppression receiving a protease inhibitor-based regimen : A randomized trialMOLINA, Jean-Michel; JOURNOT, Valérie; GOUJARD, Cécile et al.The Journal of infectious diseases. 2005, Vol 191, Num 6, pp 830-839, issn 0022-1899, 10 p.Article